Do you mean something like a "NEW" 2 bead abuse resistant technology that can be applied to all opioid pain medications? If that was the case it would be prudent for J&J to divest themselves of a soon to be obsolete franchise imo. Probably would not be so advantageous of a move for Depomed Inc. long term however if this proves to be the case imo.